Contract facts
NONENo full NAICS 325412 intel page yet. Browse NAICS intelligence
STERILE WATER FOR INJECTION 20ML is a federal NONE award for Aspr/Orm-Sns held by Pfizer Inc. Estimated value $3.9M ($11M obligated). Current period of performance ends Sep 18, 2026. Last award drew 1 bidder. Place of performance: NEW YORK NY. Related solicitation 75A50323R00006.
Recompete timing
PublicCurrent PoP ends Sep 18, 2026 (28 days remaining). Agencies typically plan 12–18 months ahead — at 0.9 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordPfizer Inc — $3.2B obligated across 1,961 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75A50325F63003?
75A50325F63003 (Sterile WATER for injection 20ml) is a Aspr/Orm-Sns award with a potential value of $3.9M, currently held by Pfizer Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75A50325F63003?
Aspr/Orm-Sns awarded 75A50325F63003 to Pfizer Inc (potential $3.9M).
Who is the incumbent on 75A50325F63003?
Pfizer Inc is the incumbent with $3.2B across 1961 related awards in SCOUT’s public footprint. The current period of performance ends Sep 18, 2026.
When does Pfizer Inc’s 75A50325F63003 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 18, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
